Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 24, 2025

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
Symptomatic Severe Aortic Stenosis
Interventions
DEVICE

Abbott BE TAVI System

Abbott BE TAVI System

Trial Locations (3)

10461

Montefiore Medical Center - Moses Division, The Bronx

55407

Abbott Northwestern Hospital, Minneapolis

67214

Via Christi Regional Medical Center, Wichita

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY